Incidental findings from cancer next generation sequencing panels

Next-generation sequencing (NGS) technologies have facilitated multi-gene panel (MGP) testing to detect germline DNA variants in hereditary cancer patients. This sensitive technique can uncover unexpected, non-germline incidental findings indicative of mosaicism, clonal hematopoiesis (CH), or hemato...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Genom Med
Autors principals: Maani, Nika, Panabaker, Karen, McCuaig, Jeanna M., Buckley, Kathleen, Semotiuk, Kara, Farncombe, Kirsten M., Ainsworth, Peter, Panchal, Seema, Sadikovic, Bekim, Armel, Susan Randall, Lin, Hanxin, Kim, Raymond H.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8289933/
https://ncbi.nlm.nih.gov/pubmed/34282142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41525-021-00224-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars